针灸用于儿童镰状细胞病疼痛管理:一种有前景的非阿片类疗法
65.5%的治疗有疼痛减轻;0–4分量表(42次)疼痛评分平均下降0.98±0.99(P<0.0001),0–10分量表(13次)下降1.23±1.09(P=0.11),未记录不良事件。
要点
- 针灸可能减轻镰状细胞病患儿疼痛,且未记录不良事件。
- 0–4分量表显示疼痛评分下降有统计学意义(P<0.0001)。
- 0–10分量表疼痛评分下降未达统计学意义(P=0.11)。
核心结论
- 针灸治疗减轻了镰状细胞病患者的疼痛,提供了一种安全的非阿片类治疗选择。
研究设计与样本
- 单中心回顾性病历审查,评估2012–2019年儿科镰状细胞病患者针灸使用情况。
- 针灸由6名持照针灸师实施,取穴基于疼痛部位、中医及日本Kiiko Matsumoto针灸理念。
主要发现
- 65.5%的(有前后评分的)治疗实现了疼痛减轻。
- 0–10分量表用于13次治疗:针灸前平均7.31±1.75,针灸后6.08±1.85,平均变化1.23±1.09(P=0.11)。
- 0–4分量表用于42次治疗:针灸前平均3.31±0.72,针灸后2.33±0.98,平均变化0.98±0.99(P<0.0001)。
- 未记录不良事件。
关键数值与推荐
- 0–4分量表:42次治疗,疼痛评分平均下降0.98±0.99,P<0.0001。
- 0–10分量表:13次治疗,疼痛评分平均下降1.23±1.09,P=0.11。
临床怎么用
- 在儿科镰状细胞病疼痛管理中,针灸可作为非阿片类治疗选项考虑。
- 治疗取穴可依据疼痛部位并结合中医与日本针灸理念。
- 治疗时长约18.5分钟(平均18.5±4.8分钟)。
局限性
- 两种疼痛量表结果不一致,0–10分量表变化未达统计学意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe the use of acupuncture for pain management in children with sickle cell disease. DESIGN: A retrospective chart review of a single-institution experience on the use of acupuncture in pediatric patients with sickle cell disease was evaluated between 2012-2019. Demographic characteristics, presenting pain location, pain scores pre- and post-acupuncture, and adverse events were collected. SETTING: Columbia University Medical Center, NewYork-Presbyterian Morgan Stanley Children's Hospital Pediatric Hematology outpatient and inpatient units. INTERVENTIONS: Acupuncture was performed by six licensed acupuncturists. Point prescriptions were based on pain location, philosophies of Traditional Chinese Medicine and Japanese Style of Kiiko Matsumoto acupuncture. MAIN OUTCOME MEASURES: Pain reduction as measured by two Verbal Pain Scales. RESULTS: Ninety acupuncture treatments were administered to twenty-four patients with sickle cell disease: median age 17.5 years, 62 % female, 37.5 % African American, 50 % Hispanic. The mean treatment duration was 18.5 ± 4.8 min. Fifty-five treatments had documented pre/post-acupuncture pain scores. Pain reduction was achieved in 65.5 % of these treatments. A 0-10 pain scale used in 13 treatments reported a mean pre-acupuncture score of 7.31 ± 1.75, post-acupuncture score of 6.08 ± 1.85, and a mean pain score change of 1.23 ± 1.09 (p = 0.11); A 0-4 pain scale used in 42 treatments reported a mean pre-acupuncture pain score of 3.31 ± 0.72, post-acupuncture score of 2.33 ± 0.98, and a mean pain score change of 0.98 ± 0.99 (p < 0.0001). No adverse events were noted. CONCLUSION: Acupuncture therapy decreased pain for our patients with sickle cell disease, providing a safe non-opioid therapeutic option.
引用
- Tsai SL, Bombacie M, Licursi M, et al. Acupuncture for pediatric sickle cell pain management: A promising non-opioid therapy. Complement Ther Med. 2020. PMID: 32147028. doi:10.1016/j.ctim.2020.102314
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。